Syngenta USA to Establish Biopharmaceutical Raw Material Manufacturing Facility in Songdo, Incheon

American multinational company Cytiva, a supplier of raw materials for biopharmaceuticals, has established a manufacturing facility in Songdo International City, Incheon.

The Incheon Free Economic Zone Authority announced on the 30th that it held an opening ceremony for the 'Cytiva Korea Innovation Hub' in Songdo-dong, Yeonsu-gu.

This facility is Cytiva's first production site in Korea, consisting of a filter manufacturing center for biopharmaceutical production processes and educational facilities. Cytiva plans to start actual product manufacturing from 2026 to flexibly respond to the demand in the Asian bio market.

The Innovation Hub will introduce various eco-friendly operational programs based on high energy and water efficiency, aiming for zero waste landfill and reduction of carbon dioxide equivalent emissions.

'Cyteva Korea Innovation Hub' Opening Ceremony
Photo by Incheon Economic Promotion Agency

Choi Junho, CEO of Cytiva Korea, stated, "We expect the newly opened Innovation Hub to meet the needs of many customers in Korea and significantly contribute to the growth of the Asian bio market," adding, "We will strive to establish this facility as a hub for collaboration and innovation with our customers."

Yoon Wonseok, head of the Incheon Free Economic Zone Authority, said, "By opening the Innovation Hub in Songdo, Cytiva, a global life sciences company, has once again demonstrated Songdo's status as a global bio hub," and added, "We will closely cooperate with Cytiva to explore ways to revitalize the bio cluster, including fostering specialized talent."

This content was produced with the assistance of AI translation services.